JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD. Financials Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
Equities
002223
CNE1000009X3
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.1 CNY | +2.25% |
|
+1.16% | +13.07% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 20,370 | 28,280 | 37,427 | 31,529 | 34,221 | 39,178 | - | - |
| Enterprise Value (EV) 1 | 18,957 | 28,280 | 37,427 | 31,529 | 34,221 | 39,178 | 39,178 | 39,178 |
| P/E ratio | 27.1 x | 16.1 x | 25.4 x | 19.8 x | 14.3 x | 17.4 x | 15.2 x | 13 x |
| Yield | 1.97% | 1.06% | 0.79% | 1.88% | 2.31% | 1.94% | 1.86% | 2.63% |
| Capitalization / Revenue | 4.39 x | 4.2 x | 5.43 x | 4.44 x | 4.29 x | 4.48 x | 3.77 x | 3.47 x |
| EV / Revenue | 4.39 x | 4.2 x | 5.43 x | 4.44 x | 4.29 x | 4.48 x | 3.77 x | 3.47 x |
| EV / EBITDA | 21.1 x | 12.7 x | 19.5 x | 15.2 x | 10.9 x | 15.6 x | 13.6 x | 11.7 x |
| EV / FCF | 116,866,821 x | 13,134,419 x | 40,819,814 x | - | - | - | - | - |
| FCF Yield | 0% | 0% | 0% | - | - | - | - | - |
| Price to Book | 3.36 x | 3.8 x | 4.58 x | 3.24 x | 2.95 x | 2.91 x | 2.5 x | 2.15 x |
| Nbr of stocks (in thousands) | 1,002,477 | 1,002,477 | 990,127 | 989,625 | 989,625 | 1,002,004 | - | - |
| Reference price 2 | 20.32 | 28.21 | 37.80 | 31.86 | 34.58 | 39.10 | 39.10 | 39.10 |
| Announcement Date | 2/28/20 | 1/28/21 | 4/22/22 | 4/27/23 | 4/26/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 4,636 | 6,726 | 6,894 | 7,102 | 7,972 | 8,748 | 10,388 | 11,277 |
| EBITDA 1 | 966.9 | 2,224 | 1,917 | 2,079 | 3,131 | 2,507 | 2,873 | 3,350 |
| EBIT 1 | 849.9 | 2,010 | 1,688 | 1,842 | 2,893 | 2,647 | 3,007 | 3,562 |
| Operating Margin | 18.33% | 29.88% | 24.48% | 25.93% | 36.3% | 30.26% | 28.95% | 31.59% |
| Earnings before Tax (EBT) 1 | 864.3 | 2,019 | 1,702 | 1,842 | 2,849 | 2,644 | 3,004 | 3,548 |
| Net income 1 | 752.6 | 1,759 | 1,482 | 1,595 | 2,396 | 2,258 | 2,574 | 3,018 |
| Net margin | 16.23% | 26.15% | 21.5% | 22.46% | 30.05% | 25.82% | 24.78% | 26.76% |
| EPS 2 | 0.7500 | 1.750 | 1.490 | 1.610 | 2.410 | 2.252 | 2.568 | 3.013 |
| Free Cash Flow | 174.3 | 2,153 | 916.9 | - | - | - | - | - |
| FCF margin | 3.76% | 32.01% | 13.3% | - | - | - | - | - |
| FCF Conversion (EBITDA) | 18.03% | 96.83% | 47.84% | - | - | - | - | - |
| FCF Conversion (Net income) | 23.16% | 122.4% | 61.85% | - | - | - | - | - |
| Dividend per Share 2 | 0.4000 | 0.3000 | 0.3000 | 0.6000 | 0.8000 | 0.7600 | 0.7275 | 1.030 |
| Announcement Date | 2/28/20 | 1/28/21 | 4/22/22 | 4/27/23 | 4/26/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 2,277 | 1,683 | 1,309 | 2,231 | 2,282 | 2,060 | 2,616 |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT | - | - | - | - | - | - | - | - |
| Operating Margin | - | - | - | - | - | - | - | - |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - | - |
| Net income | 713.5 | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - |
| EPS | 0.7186 | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 4/28/23 | 8/28/23 | 10/24/23 | 4/26/24 | 4/26/24 | - | - | - |
1CNY in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - | - |
| Net Cash position | 1,413 | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow | 174 | 2,153 | 917 | - | - | - | - | - |
| ROE (net income / shareholders' equity) | 13.1% | 26.2% | 19.2% | 17.5% | 22.5% | 16.7% | 16.5% | 16.5% |
| ROA (Net income/ Total Assets) | 10% | 19.5% | 13.4% | 11.8% | - | 13.4% | 12.3% | 14% |
| Assets 1 | 7,495 | 9,015 | 11,032 | 13,547 | - | 16,917 | 20,869 | 21,558 |
| Book Value Per Share 2 | 6.060 | 7.420 | 8.250 | 9.840 | 11.70 | 13.40 | 15.70 | 18.20 |
| Cash Flow per Share 2 | 0.6100 | 2.820 | 1.200 | 2.300 | 2.120 | 1.890 | 2.410 | 2.770 |
| Capex 1 | 440 | 678 | 284 | 178 | - | 242 | 281 | 233 |
| Capex / Sales | 9.49% | 10.08% | 4.11% | 2.5% | - | 2.76% | 2.71% | 2.07% |
| Announcement Date | 2/28/20 | 1/28/21 | 4/22/22 | 4/27/23 | 4/26/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
39.1
CNY
Average target price
46.79
CNY
Spread / Average Target
+19.66%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +13.07% | 5.43B | |
| +73.43% | 12.41B | |
| -16.51% | 8.14B | |
| +16.03% | 7.2B | |
| +4.95% | 5.93B | |
| +36.46% | 4.89B | |
| -19.82% | 4.09B | |
| -34.06% | 2.49B | |
| +1.73% | 2.04B | |
| +10.14% | 1.98B |
- Stock Market
- Equities
- 002223 Stock
- Financials Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.